-
Early Life Adversity, Oxytocin, and Visual Fear
2026-09-02
Tan et al. show that social deprivation during a defined early developmental window weakens looming-evoked innate defensive behavior in mice and connect this deficit to oxytocin receptor signaling in the superior colliculus. The study combines behavioral, molecular, circuit, causal knockdown, and pharmacological rescue evidence, providing a mechanistic framework for studying how early adversity alters threat processing.
-
Tropisetron Hydrochloride: 5-HT3 Research Guide
2026-09-01
Tropisetron Hydrochloride is a selective 5-HT3 receptor antagonist used in receptor pharmacology and transporter research. Product data report an IC50 of 70.1 ± 0.9 nM for the 5-HT3 receptor, while peer-reviewed in vitro evidence shows that tropisetron can inhibit renal OCT2 and MATE1 transport.
-
Guanabenz Acetate in GPCR Signaling Workflows
2026-09-01
Guanabenz Acetate provides a concentration-resolved way to interrogate α2-adrenergic receptor signaling across receptor pharmacology and neuroimmune assay systems. This guide connects practical formulation, subtype-aware dosing, stress-granule readouts, and troubleshooting without overstating an unproven antiviral mechanism.
-
MOG (35-55) for EAE Research Workflows
2026-08-31
MOG (35-55) provides a defined myelin oligodendrocyte glycoprotein peptide for building reproducible EAE models and neuroinflammation assays. This guide connects peptide handling and dose optimization with the PARP7–STAT1/STAT2 mechanism reported in recent multiple sclerosis research.
-
Inhaled RNA Rebuilds the Lung Cancer TME
2026-08-31
The reference study develops an inhalable lipid nanoparticle that co-delivers anti-DDR1 mRNA and PD-L1 siRNA to address both collagen-mediated immune exclusion and checkpoint-mediated immunosuppression in lung cancer. In orthotopic and metastatic mouse models, this dual-action strategy remodeled collagen architecture, reduced tumor stiffness, promoted tumor regression, and extended survival.
-
AICAR Workflows for AMPK Metabolic Research
2026-08-30
Use AICAR as a controllable AMPK probe to connect energy metabolism regulation with mitochondrial quality control, muscle atrophy, and inflammatory signaling. This workflow combines practical dosing, solubility handling, pathway-level controls, and readout selection for more reproducible metabolic disease research.
-
Cy3 TSA Fluorescence System Kit Workflow Guide
2026-08-29
Build sensitive IHC, ICC, and ISH workflows around HRP-mediated tyramide deposition for spatially precise visualization of scarce targets. This guide connects the Cy3 TSA Fluorescence System Kit with structure-informed olfactory receptor research while emphasizing practical controls, optimization, and troubleshooting.
-
Sorafenib: A Mechanistic Antiangiogenesis Guide
2026-08-28
Sorafenib and BAY-43-9006 are powerful reference compounds for separating tumor-cell signaling from VEGFR-driven angiogenesis. This guide translates comparative VEGFR-2 research into practical assay design, model selection, dosing interpretation, and mechanistic validation.
-
Gallein Workflows for Gβγ Signaling Research
2026-08-28
Gallein is a practical G protein βγ subunit inhibitor for separating shared GPCR effector signaling from receptor-specific effects. This workflow guide connects cancer metastasis inhibition, macrophage polarization modulation, cardiac disease models, and the emerging lactate-GPR81 metabolic pathway while emphasizing assay controls and troubleshooting.
-
Polyethylenimine Linear (PEI), MW 40,000
2026-08-27
Polyethylenimine Linear (PEI), MW 40,000 is a cationic DNA transfection reagent for in vitro studies. Its electrostatic DNA condensation mechanism supports transient gene expression and recombinant protein production, while supplier-reported efficiency and scale depend on cell type and experimental conditions.
-
AM251: CB1 Receptor Antagonist Workflows
2026-08-27
AM251 is a potent CB1 receptor antagonist for separating central cannabinoid signaling from ligand-independent assay effects. This practical guide connects receptor pharmacology with behavioral pain models, obesity treatment research, apoptosis assays, and cell-cycle workflows while emphasizing solvent control and mechanistic validation.
-
DRB: Mechanism, Evidence, and Research Use
2026-08-26
5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole (DRB) is a broad transcriptional elongation and CDK-pathway research inhibitor. Its strongest documented benchmarks include CTD-kinase inhibition, reduced HeLa hnRNA synthesis, HIV transcription inhibition, and in-vitro activity against influenza virus.
-
Macrophage Depletion as a Test of Immune Aging
2026-08-26
A mechanistic and translational framework for using Clodronate Liposomes to distinguish macrophage abundance from macrophage competence in aging, inflammation, and disease models.
-
Resazurin Cell Viability Assay Kit: Practical Workflow
2026-08-25
Build a sensitive, wash-free cell viability assay around fluorescence or colorimetric resorufin detection. This workflow shows how K2234 can support parthenolide response profiling, high-throughput screening, and mechanistic follow-up while avoiding common metabolic-assay artifacts.
-
Polyethylenimine Linear: DNA Delivery Decisions
2026-08-25
Polyethylenimine Linear (PEI), MW 40,000 supports serum-compatible DNA delivery, transient gene expression, and recombinant protein production. This guide adds a formulation-focused framework informed by kidney-targeted mRNA nanoparticle research, helping researchers distinguish transfection efficiency from meaningful biological performance.